CATALOGO DEI PRODOTTI DELLA RICERCA

MAGLIOZZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.639
EU - Europa 1.433
AS - Asia 729
OC - Oceania 6
SA - Sud America 5
AF - Africa 2
Totale 3.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.614
CN - Cina 555
GB - Regno Unito 446
IT - Italia 206
SE - Svezia 201
IE - Irlanda 169
FR - Francia 166
DE - Germania 110
VN - Vietnam 74
SG - Singapore 66
FI - Finlandia 45
UA - Ucraina 36
CA - Canada 25
BE - Belgio 13
KR - Corea 12
NL - Olanda 9
AT - Austria 7
HK - Hong Kong 7
RU - Federazione Russa 6
AU - Australia 5
CH - Svizzera 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
CL - Cile 2
HR - Croazia 2
IN - India 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
PL - Polonia 2
SC - Seychelles 2
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
IM - Isola di Man 1
IQ - Iraq 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.814
Salva come PNG Salva come JPEG
Città #
Chandler 428
Southend 424
Jacksonville 185
Dublin 169
Ashburn 118
Beijing 90
Verona 89
Princeton 78
Lawrence 71
Ann Arbor 65
Jinan 61
Wilmington 58
Dong Ket 56
Nanjing 50
Woodbridge 47
Redmond 42
Houston 34
Singapore 34
Shenyang 29
Tianjin 29
Changsha 26
Ningbo 24
Montréal 23
Sindelfingen 23
Zhengzhou 23
Munich 22
Taizhou 22
Haikou 21
Helsinki 20
Hebei 19
Redwood City 19
Hangzhou 17
Lancaster 17
Nanchang 17
New York 16
Jiaxing 14
Seattle 14
Brussels 13
Lappeenranta 13
Norwalk 13
Washington 13
Guangzhou 12
Mcallen 12
Rome 12
Seoul 12
Falls Church 10
Vienna 7
Fairfield 6
Fuzhou 6
Hong Kong 6
Milan 6
Padova 6
Taiyuan 6
Bologna 5
Duncan 5
Los Angeles 5
Cambridge 4
Chicago 4
Clearwater 4
Kent 4
Pordenone 4
Amsterdam 3
Boardman 3
Dearborn 3
Dongguan 3
Groningen 3
Lanzhou 3
Menlo Park 3
Olgiate Olona 3
Zurich 3
Albiate 2
Bonndorf 2
Boydton 2
Buenos Aires 2
Canberra 2
Ferrara 2
London 2
Melbourne 2
Palermo 2
Riva 2
Saint Louis 2
Sofia 2
Struga 2
Vientiane 2
Xiangfen 2
Zagreb 2
Almere Stad 1
Atlanta 1
Auckland 1
Austin 1
Bangkok 1
Buffalo 1
Böblingen 1
Capoterra 1
Dhaka 1
Douglas 1
Düsseldorf 1
Fairport 1
Florence 1
Frankfurt am Main 1
Totale 2.755
Salva come PNG Salva come JPEG
Nome #
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 100
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 95
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 90
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis 90
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 87
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 81
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 80
Epilepsy in multiple sclerosis: The role of temporal lobe damage 78
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 77
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 76
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 74
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 74
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 73
Exploring the origins of grey matter damage in multiple sclerosis. 70
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 66
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 65
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis 65
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice 65
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 63
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 63
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 62
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells 62
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 62
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 60
Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV 59
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats 57
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 57
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies 57
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 56
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 55
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 54
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 54
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 53
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis 52
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain 52
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 52
Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon 51
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis 51
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 50
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis 49
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis 49
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look 47
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology 47
Aging, cellular senescence, and progressive Multiple Sclerosis 47
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 46
Meningeal inflammation and cortical demyelination in acute multiple sclerosis 46
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 46
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination 45
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 43
Can CSF biomarkers predict future MS disease activity and severity? 42
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein 41
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 41
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis 40
Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis 40
The BAFF / APRIL system as therapeutic target in multiple sclerosis 40
A gradient of neuronal loss and meningeal inflammation in multiple sclerosis 39
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 38
Lymphoid chemokines in chronic neuroinflammation 38
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury 36
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis 36
Intracerebral regulation of immune responses 34
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation 33
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome 32
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 31
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study 30
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 30
Surface-in pathology in multiple sclerosis: a new view on pathogenesis? 28
A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis 27
Editorial: B cells in inflammatory and neurodegenerative diseases of the central nervous system 27
Intrathecal inflammation in progressive multiple sclerosis 25
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 25
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis 23
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation 23
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 12
Differences in age-related retinal and cortical atrophy rates in multiple sclerosis 12
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis 11
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 10
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 9
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 8
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis 6
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 6
Comparing the pathology, clinical and demographic characteristics of younger and older-onset multiple sclerosis 5
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 3
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis 3
Totale 3.937
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.802
article - articoli 15.440
book - libri 0
conference - conferenze 362
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.604
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020394 44 12 4 2 69 82 57 3 5 32 38 46
2020/2021587 82 102 18 68 69 64 15 4 14 12 64 75
2021/2022556 36 171 1 72 18 7 19 40 20 19 30 123
2022/20231.208 86 147 115 223 68 282 22 69 157 4 18 17
2023/2024612 17 50 48 62 74 87 46 50 2 60 84 32
Totale 3.937